These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1363485)

  • 41. Yawning produced by dopamine agonists in rhesus monkeys.
    Code RA; Tang AH
    Eur J Pharmacol; 1991 Aug; 201(2-3):235-8. PubMed ID: 1686760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM; Barnes NM; Costall B; Naylor RJ
    Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
    Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
    Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR; Minaian A
    Gen Pharmacol; 1991; 22(6):1017-21. PubMed ID: 1687391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1991 Aug; 201(1):11-6. PubMed ID: 1686587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
    Pacheco-Cano MT; Bargas J; Hernández-López S; Tapia D; Galarraga E
    Exp Brain Res; 1996 Jul; 110(2):205-11. PubMed ID: 8836685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.
    Mazurski EJ; Beninger RJ
    Psychopharmacology (Berl); 1991; 105(1):107-12. PubMed ID: 1684056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    Winkler JD; Weiss B
    J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR; Eliassi A
    Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats.
    Levin ED; Ellison GD; See RE; South D; Young E
    Pharmacol Biochem Behav; 1989 Jul; 33(3):501-5. PubMed ID: 2573903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.
    Wu M; Brudzynski SM; Mogenson GJ
    Brain Res Bull; 1993; 32(4):395-8. PubMed ID: 8106125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine D1 and D2 effects on fetal mouthing responses to milk.
    Smotherman WP; Robinson SR
    Physiol Behav; 1995 Jan; 57(1):15-9. PubMed ID: 7878109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.